O
Organovo Holdings
ONVO
0.54460
USD
-0.0154
(-2.75%)
مغلق
حجم التداول
745
الربح لكل سهم
0
العائد الربحي
0
P/E
-0
حجم السوق
7,221,116
الأخبار
العنوان: Organovo Holdings
القطاع: Healthcare
الصناعة: Biotechnology
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.